Risk of Keratitis and Keratopathy in Hidradenitis Suppurativa Patients: A Global Federated Health Network Analysis

• Published in: In vivo (Athens) Vol. 38; no. 3; pp. 1375 - 1383
• Main Authors: GAU, SHUO-YAN, LIU, PIN-YU, CHEN, SAN-NI, CHIU, TSU-MAN, TSAI, RU-YIN, CHANG, HUI-CHIN, LI, CHEN-PI
• Format: Journal Article
• Language: English
• Published: Greece International Institute of Anticancer Research 01.05.2024
• Subjects: Adolescent; Adult; Case reports; Cohort analysis; Collaboration; Cornea; Corneal Diseases - complications; Corneal Diseases - epidemiology; Corneal Diseases - etiology; Eye diseases; Female; Females; Health care networks; Hidradenitis Suppurativa - complications; Hidradenitis Suppurativa - epidemiology; Humans; Inflammation; Inflammatory bowel disease; Keratitis - epidemiology; Keratitis - etiology; Male; Middle Aged; Patients; Prevalence; Psoriasis; Retrospective Studies; Risk Factors; Tumor necrosis factor-TNF; Young Adult; United States > US; keratopathy; epidemiology; keratitis; cohort; electronic medical records; Hidradenitis suppurativa
• ISSN: 0258-851X; 1791-7549; 1791-7549
• DOI: 10.21873/invivo.13578

Hidradenitis suppurativa (HS) is linked to immune dysregulation and systemic inflammation. While previous studies indicate a higher prevalence of ocular manifestations in HS, the specific risk of keratopathy and keratitis remains unclear. The primary aim of this study was to assess the risk of keratitis and keratopathy in individuals with HS. In this retrospective cohort study conducted with data from the TriNetX database, 53,716 patients with HS were matched to an equivalent number of non-HS controls using propensity score matching. The study covered the period from January 1st, 2005, to December 31st, 2017. Hazard ratios and their respective 95% confidence intervals (CIs), were computed to evaluate the occurrences of keratitis and keratopathy over a 5-year duration in patients with HS, compared to non-HS controls. HS was associated with a 1.52 times higher risk of keratitis over a 5-year period (95%CI=1.24-1.86) and a 1.47 times higher risk of keratopathy (95%CI=1.18-1.84). These risks remained consistent in sensitivity analyses. The elevated risk of keratitis was observed across both sexes. However, the risk of keratopathy was significantly higher in women with HS (HR=1.61, 95%CI=1.24-2.10) and individuals aged 18-64 years (HR=1.32, 95%CI=1.04-1.68). HS was linked to an elevated risk of both keratitis and keratopathy over a 5-year period. Ophthalmologic manifestations are recommended to be considered in HS standard care.